INTERIM REPORT FROM A PHASE 2 MULTICENTER STUDY OF...

Hematological Oncology 2017 / 06 Vol. 35

INTERIM REPORT FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMAS

Morschhauser, F., Salles, G., McKay, P., Tilly, H., Schmitt, A., Gerecitano, J., Johnson, P., Le Gouill, S., Dickinson, M.J., Fruchart, C., Lamy, T., Chaidos, A., Jurczak, W., Opat, S., Radford, J., Z
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_3
Date:
June, 2017
File:
PDF, 89 KB
english, 2017
Conversion to is in progress
Conversion to is failed